Understanding how GLP-1 medications work, what realistic outcomes to expect, and who may be suitable for treatment is essential for informed decision-making
In May 2025, Bank of America set a $70 price target, crowing about the Novo Nordisk deal as a growth rocket for Hims weight loss segment
Off-label benefits of GLP-1s are also being evaluated, some of which include improvement in inflammation and arthritis issues, metabolic disorders, addiction disorders (gambling, alcoholism, drugs) and possible benefits for hormone-driven cancers
GLP-1 visits happen in a Carrollwood medical office, not through a shipping-only app
Potential benefits reported by some patients may include reduced appetite, prolonged feelings of fullness, and decreased food intake